Pulse
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
Mukka Proteins Limited

Mukka Proteins Limited

NSE: MUKKA
Packaged FoodsConsumer DefensiveSMALL CAPMCap ₹837.3 Cr
₹27.91₹-0.95 (-3.29%)

Market Closed • NSE

Market cap₹837.3 Cr
Enterprise value₹1.61k Cr
P/E TTM12.08
P/B1.67
EPS TTM₹2.31
ROCE11.10%
D/E1.47
Dividend yield0.00%
Face value₹1.00
52W high₹33.29
52W low₹18.27
Price chart(1Y)
1Y Return:+22.36% (+₹5.10)
H: ₹33.29L: ₹21.06
1W+6.08%
1M-1.31%
3M+20.67%
6M+13.64%
1Y+11.64%
Today at a glance

Day range

₹27.50₹29.00

52 week range

₹18.27₹33.29
Volume252.6K0.95x 20D avg
Free float50.00%-5.50% volume

Mukka Proteins Limited closed at INR27.91 (-3.29%) on volume 0.95x its 20-day average, trading 16.16% below its 52-week high.

Technical analysis
RSI (14)53.0Neutral (30–70)
MACDBULLISHBullish (Above signal)
ATR (14)₹1.45High
SMA 20₹27.08BULLISH
SMA 50₹27.33BULLISH
SMA 100₹25.30BULLISH
SMA 200₹24.11BULLISH
CPR bottom₹29.18
Pivot₹29.07
CPR top₹28.97
What changed recently?

2026-Q2

Q2 FY2026 Financial Results

PAT moved +0% QoQ

Shariah audit
Methodology: AAOIFI Shariah Standard No. 21
FAIL3/4 criteria
Non-Compliant (Financial Ratios)
CriteriaNumeratorDenominatorValueThresholdStatus
Interest-bearing debt ratio₹779.3 Cr₹837.3 Cr93.07%≤ 33%FAIL
Non-halal income ratio–₹1.40k Cr0.00%≤ 5%PASS
Illiquid assets ratio₹1.61k Cr₹1.62k Cr99.21%≥ 20%PASS
Receivables ratio–₹1.62k Cr—≤ 49%PASS
Valuation & sector context
MetricCompanySector
P/E12.0821.90
Forward P/E——
P/B1.672.40
EV/EBITDA—18.00
PEG—1.30
Earnings yield8.304.60
Growth & profitability
RevenuePAT
FY24PAT margin 5.20%
FY25PAT margin 4.70%
FY26PAT margin 3.70%

Revenue and PAT bars use independent scales to make their year-on-year direction readable.

Revenue CAGR 3Y+16.50%
Revenue CAGR 5Y+0.90%
PAT CAGR 3Y+7.40%
PAT CAGR 5Y-5.80%
Operating margin8.82%
Net margin3.93%
Financial health & cash flow
Net debt₹766.4 CrModerate
Interest coverage1.80xEBIT / interest
CFO / PAT-2.73x3Y average
Net debt / EBITDA—Leverage
Operating cash flow₹-11126.5 Lakh
Capital expenditure–
Free cash flow₹-23181.4 Lakh
Financial statements

Complete reported financial history · Values use the company's reporting currency

Hover over the chart for exact reported values. Percentage lines use the right-hand axis.

Fundamental scorecard
Overall63/100
Valuation75/100
Profitability65/100
Financial health50/100

A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.

Strengths, risks & investment thesis

Strengths

Attractive Valuation: P/E of 12.1x trades below sector historical averages

Risks

Tight Debt Servicing: Interest coverage ratio is under 2.0x

Bull case

Market Leadership: Established operational scale in Packaged Foods.

Bear case

Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.

Flip condition

Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.

Shareholding pattern
Quarterly ownership historyLatest valid period · December 2024

Ownership distribution

Dec 2024Latest holding

Category trends

Hover over a period for exact holdings

80%53%27%0%Sept 2024Dec 2024
1.73%Institutional holding
24.93%Public holding
2Periods available
0.00%Promoter pledged
1.28LShareholders
Delivery participation

Traded volume and delivery percentage across the latest 15 sessions

Average delivery (15D)48.28%+9.61% latest vs average
Highest delivery66.43%on 28 Aug
Average volume (15D)2.03MTrading-session average
Conviction trendStrengthening+9.61% latest reading
Traded volumeDelivery %
Peer comparison

Compare valuation, latest quarterly performance and year-on-year growth

8 companies
Company nameMarket cap ₹ CrP/E ratioDividend yield %Quarterly sales ₹ CrProfit after tax ₹ CrSales growth %Profit growth %
Hindustan Unilever Limited
Hindustan Unilever LimitedHINDUNILVR
Open analysis
₹4.45L42.462.32%₹17,341.00₹2,680.00+10.05%-3.18%
ITC Limited
ITC LimitedITC
Open analysis
₹3.30L16.646.06%₹19,114.00₹4,509.00-11.08%-15.61%
Nestlé India Limited
Nestlé India LimitedNESTLEIND
Open analysis
₹2.44L59.830.94%₹6,378.00₹959.00+25.16%+48.22%
Avenue Supermarts Limited
Avenue Supermarts LimitedDMART
Open analysis
₹2.18L69.890.00%₹18,795.00₹860.00+14.88%+11.25%
Varun Beverages Limited
Varun Beverages LimitedVBL
Open analysis
₹1.46L43.050.47%₹8,451.00₹1,525.00+20.44%+15.09%
Britannia Industries Limited
Britannia Industries LimitedBRITANNIA
Open analysis
₹1.15L44.071.87%₹5,000.00₹593.00+8.18%+14.04%
Marico Limited
Marico LimitedMARICO
Open analysis
₹1.02L53.910.51%₹3,957.00₹652.00+22.85%+27.10%
UNITED SPIRITS LIMITED
UNITED SPIRITS LIMITEDUNITDSPR
Open analysis
₹97,987.6558.111.23%₹3,054.00₹539.00+3.67%+28.03%
About Mukka Proteins Limited
Mukka Proteins Limited

Incorporated in 2003, Mukka Proteins Ltd is a manufacturer and exporter of Fish Meal and Fish oil[1]

IndiaConsumer Defensive

Questions investors ask
Is Mukka Proteins Limited Shariah compliant?

Mukka Proteins Limited is currently screened as Non-Compliant (Financial Ratios) under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (93.07%) exceeds AAOIFI threshold (≤ 33%).

What is Mukka Proteins Limited's current valuation relative to peers?

Mukka Proteins Limited trades at a P/E of 12.1x compared to the sector median of 21.9x, and a Price-to-Book of 1.7x.

Is the company financially healthy?

The company has a Debt-to-Equity ratio of 1.47x. Interest coverage is 1.8x.

What are the historical revenue and profit growth rates?

Over the past 5 years, revenue compounded at 0.9% while net profit growth averaged -5.8%.

Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.

Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.